82 related articles for article (PubMed ID: 17569638)
1. Proteomics analyses of ovarian cancer using genetically defined human ovarian cancer models.
Cheng X; Young TW; Mei FC
Front Biosci; 2007 Sep; 12():5166-74. PubMed ID: 17569638
[TBL] [Abstract][Full Text] [Related]
2. Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.
Young T; Mei F; Liu J; Bast RC; Kurosky A; Cheng X
Oncogene; 2005 Sep; 24(40):6174-84. PubMed ID: 15940260
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of tumor susceptibility gene 101 protein in ovarian carcinomas revealed by proteomics analyses.
Young TW; Mei FC; Rosen DG; Yang G; Li N; Liu J; Cheng X
Mol Cell Proteomics; 2007 Feb; 6(2):294-304. PubMed ID: 17110434
[TBL] [Abstract][Full Text] [Related]
4. Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry.
Young TW; Mei FC; Yang G; Thompson-Lanza JA; Liu J; Cheng X
Cancer Res; 2004 Jul; 64(13):4577-84. PubMed ID: 15231669
[TBL] [Abstract][Full Text] [Related]
5. A genetically defined model for human ovarian cancer.
Liu J; Yang G; Thompson-Lanza JA; Glassman A; Hayes K; Patterson A; Marquez RT; Auersperg N; Yu Y; Hahn WC; Mills GB; Bast RC
Cancer Res; 2004 Mar; 64(5):1655-63. PubMed ID: 14996724
[TBL] [Abstract][Full Text] [Related]
6. Tumor promoting properties of the ETS protein MEF in ovarian cancer.
Yao JJ; Liu Y; Lacorazza HD; Soslow RA; Scandura JM; Nimer SD; Hedvat CV
Oncogene; 2007 Jun; 26(27):4032-7. PubMed ID: 17213815
[TBL] [Abstract][Full Text] [Related]
7. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.
Yang G; Rosen DG; Zhang Z; Bast RC; Mills GB; Colacino JA; Mercado-Uribe I; Liu J
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16472-7. PubMed ID: 17060621
[TBL] [Abstract][Full Text] [Related]
8. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras.
MacKenzie KL; Franco S; Naiyer AJ; May C; Sadelain M; Rafii S; Moore MA
Oncogene; 2002 Jun; 21(27):4200-11. PubMed ID: 12082607
[TBL] [Abstract][Full Text] [Related]
9. C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro.
Kusakari T; Kariya M; Mandai M; Tsuruta Y; Hamid AA; Fukuhara K; Nanbu K; Takakura K; Fujii S
Br J Cancer; 2003 Dec; 89(12):2293-8. PubMed ID: 14676809
[TBL] [Abstract][Full Text] [Related]
10. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
11. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
Llauradó M; Abal M; Castellví J; Cabrera S; Gil-Moreno A; Pérez-Benavente A; Colás E; Doll A; Dolcet X; Matias-Guiu X; Vazquez-Levin M; Reventós J; Ruiz A
Int J Cancer; 2012 Apr; 130(7):1532-43. PubMed ID: 21520040
[TBL] [Abstract][Full Text] [Related]
12. RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells.
Mei FC; Young TW; Liu J; Cheng X
FASEB J; 2006 Mar; 20(3):497-9. PubMed ID: 16384911
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells.
Huang M; Page C; Reynolds RK; Lin J
Gynecol Oncol; 2000 Oct; 79(1):67-73. PubMed ID: 11006034
[TBL] [Abstract][Full Text] [Related]
14. RAS oncogenic signal upregulates EZH2 in pancreatic cancer.
Fujii S; Fukamachi K; Tsuda H; Ito K; Ito Y; Ochiai A
Biochem Biophys Res Commun; 2012 Jan; 417(3):1074-9. PubMed ID: 22222375
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.
Sasaki R; Narisawa-Saito M; Yugawa T; Fujita M; Tashiro H; Katabuchi H; Kiyono T
Carcinogenesis; 2009 Mar; 30(3):423-31. PubMed ID: 19126650
[TBL] [Abstract][Full Text] [Related]
16. Sheep stromal-epithelial cell interactions and ovarian tumor progression.
Wang-Johanning F; Huang M; Liu J; Rycaj K; Plummer JB; Barnhart KF; Satterfield WC; Johanning GL
Int J Cancer; 2007 Nov; 121(10):2346-54. PubMed ID: 17657741
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells.
Burke WM; Jin X; Lin HJ; Huang M; Liu R; Reynolds RK; Lin J
Oncogene; 2001 Nov; 20(55):7925-34. PubMed ID: 11753675
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
[TBL] [Abstract][Full Text] [Related]
19. DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.
Zhao R; Cui T; Han C; Zhang X; He J; Srivastava AK; Yu J; Wani AA; Wang QE
Nucleic Acids Res; 2015 Sep; 43(16):7838-49. PubMed ID: 26130719
[TBL] [Abstract][Full Text] [Related]
20. Analysis of gene expression regulated by the ETV5 transcription factor in OV90 ovarian cancer cells identifies FOXM1 overexpression in ovarian cancer.
Llauradó M; Majem B; Castellví J; Cabrera S; Gil-Moreno A; Reventós J; Ruiz A
Mol Cancer Res; 2012 Jul; 10(7):914-24. PubMed ID: 22589409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]